Skip to main content
International Journal of Endocrinology logoLink to International Journal of Endocrinology
. 2017 Jul 16;2017:4576102. doi: 10.1155/2017/4576102

Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences”

Giuseppina T Russo 1,*, Annalisa Giandalia 1, Elisabetta L Romeo 1, Nunziata Morabito 1, Marco Muscianisi 1, Maria Concetta Ruffo 1, Antonino Catalano 1, Domenico Cucinotta 1
PMCID: PMC5534273  PMID: 28791046

In the article titled “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” [1], with regard to the FRAX® tool, it has been reported that “Among the different tools to assess fracture risk, the WHO fracture risk assessment (FRAX) is a computer based algorithm (http://www.shef.ac.uk/FRAX/) primarily intended for use in primary care [56, 57].” We point out that the metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. Additionally, the name of the fourth author was given incorrectly as Morabito Nunziata. The author's name should have been written as Nunziata Morabito. The revised authors' list is shown above.

References

  • 1.Russo G. T., Giandalia A., Romeo E. L., et al. Fracture risk in type 2 diabetes: current perspectives and gender differences. International Journal of Endocrinology. 2016;2016:11. doi: 10.1155/2016/1615735.1615735 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ford N., Norris S. L., Hill S. R. Clarifying WHO’s position on the FRAX® tool for fracture prediction. Bulletin of the World Health Organization. 2016;94(12):p. 862. doi: 10.2471/BLT.16.188532. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Endocrinology are provided here courtesy of Wiley

RESOURCES